Tracking cancer cells by IVIS after 3 weeks of injections of vehicle or PXS-S1C (30 mg/kg) demonstrated that inhibition of LOXL2 by PXS-S1C significantly decreased the distribution of cancer cells to other tissues (Fig. 2b, c). This evidence concerns the gene LOXL2 and cancer.